NCT01430078View on ClinicalTrials.gov

A Study to Assess the Bioavailability of ASP015K

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Healthy
Interventions
DRUG

ASP015K

oral tablet

DRUG

ASP015K

solution via oral capsule

Trial Locations (1)

NG116JS

Quotient Clinical Limited, Ruddington

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY